Atkins Diabetes Revolution (67 page)

2. Bazzano, L. A., He, J., Ogden, L. G., et al.,“Fruit and Vegetable In- take and Risk of Cardiovascular Disease in US Adults: The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study,”
American Journal of Clinical Nutrition,
76(1), 2002, pages 93–99.

3. Williams, D. E., Wareham, N. J., Cox, B. D., et al.,“Frequent Salad Vegetable Consumption Is Associated with a Reduction in the Risk of Diabetes Mellitus,”
Journal of Clinical Epidemiology,
52(4), 1999, pages 329–335.

4. Johnston, C. S., Taylor, C. A., Hampl, J. S., “More Americans Are Eating ‘5 a Day’ but Intakes of Dark Green and Cruciferous Vegetables Remain Low,”
Journal of Nutrition,
130(12), 2000, pages 3063–3067.

5. Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,”
American Journal of Clinical Nutrition,
76(1), 2002, pages 5–56.

6. Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?”
Diabetes
Educator,
17(4), 1991, pages 274–278.

7. Bolton, R. P., Heaton, K.W., Burroughs, L. F.,“The Role of Dietary Fiber in Satiety, Glucose, and Insulin: Studies with Fruit and Fruit Juice,”
American Journal of Clinical Nutrition,
34(2), 1981, pages 211–217.

8. Gannon, M. C., Nuttall, F. Q., Krezowski, P. A., et al., “The Serum Insulin and Plasma Glucose Responses to Milk and Fruit Products in Type 2 (Non-Insulin-Dependent) Diabetic Patients,”
Diabetologia,
29(11), 1986, pages 784–791.

9. Hayden, M. R., Tyagi, S. C.,“Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,”
Journal of the
Pancreas,
3(4), 2002, pages 86–108.

10. Hayden, M. R., Tyagi, S. C.,“Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,”
Journal of the
Pancreas,
3(4), 2002, pages 86–108.

11. Nelson, J. L., Bernstein, P. S., Schmidt, M. C., et al.,“Dietary Modi- fication and Moderate Antioxidant Supplementation Differentially Affect Serum Carotenoids, Antioxidant Levels and Markers of Oxidative Stress in Older Humans,”
Journal of Nutrition,
133(10), 2003, pages 3117–3123.

12. Ford, E. S., Mokdad,A. H., Giles,W. H., et al.,“The Metabolic Syndrome and Antioxidant Concentrations: Findings from the Third National Health and Nutrition Examination Survey,”
Diabetes,
52(9), 2003, pages 2346–2352.

13. Fung, T. T., Manson, J. E., Solomon, C. G., et al.,“The Association Between Magnesium Intake and Fasting Insulin Concentration in Healthy Middle-Aged Women,”
Journal of the American College of
Nutrition,
22(6), 2003, pages 533–538.

14. Seddon, J. M., Ajani, U. A., Sperduto, R. D., et al., “Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration. Eye Disease Case-Control Study Group,”
Journal of the American Medical Association,
272(18), 1994, pages 1413–1420.

Chapter 17: Controlling Your Carbs—and Liking It

1. Wursch, P., Pi-Sunyer, F. X.,“The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes.A Review with Special Emphasis on Cereals Rich in Beta-Glucan,”
Diabetes Care,
20(11), 1997, pages 1774–1780.

2. Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,”
American Journal of Clinical Nutrition,
76(1), 2002, pages 5–56.

3. Chiasson, J. L., Josse, R. G., Gomis, R., et al.,“Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomised Trial,”
Lancet,
359(9323), 2002, pages 2072–2077.

4. Kaiser, T., Sawicki, P. T.,“Acarbose for Prevention of Diabetes, Hypertension and Cardiovascular Events? A Critical Analysis of the STOP-NIDDM Data,”
Diabetologia,
47(3), 2004, pages 575–580.

Chapter 18: Sugar Nation

1. USDA,“Major Trends in U.S.Food Supply,1909–99
,” FoodReview,
23(1), 2000, pages 8–15.

2. Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?”
Diabetes
Educator,
17(4), 1991, pages 274–278.

3. Natah, S. S., Hussien, K. R., Tuominen, J. A., et al.,“Metabolic Response to Lactitol and Xylitol in Healthy Men,”
American Journal of Clinical Nutrition,
65(4), 1997, pages 947–950.

4. USDA,“Major Trends in U.S.Food Supply,1909–99
,” FoodReview,
23(1), 2000, pages 8–15.5. Elliott, S. S., Keim, N. L., Stern, J. S., et al.,“Fructose, Weight Gain, and the Insulin Resistance Syndrome
,” American Journal of Clinical Nutrition,
76(5), 2002, pages 911–922.

Chapter 19: Drink to Your Health

1. Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,”
American Journal of Clinical Nutrition,
76(1), 2002, pages 5–56.

2. Bolton, R. P., Heaton, K.W., Burroughs, L. F.,“The Role of Dietary Fiber in Satiety, Glucose, and Insulin: Studies with Fruit and Fruit Juice
,” American Journal of Clinical Nutrition,
34(2), 1981, pages 211–217.

3. Gannon, M. C., Nuttall, F. Q., Krezowski, P. A., et al., “The Serum Insulin and Plasma Glucose Responses to Milk and Fruit Products in Type 2 (Non-Insulin-Dependent) Diabetic Patients
,” Diabetologia,
29(11), 1986, pages 784–791.

4. Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?
” Diabetes
Educator,
17(4), 1991, pages 274–278.

5. Zemel, M. B., “Role of Dietary Calcium and Dairy Products in Modulating Adiposity,”
Lipids,
38(2), 2003, pages 139–146.

6. Kerr, D., Sherwin, R. S., Pavalkis, F., et al.,“Effect of Caffeine on the Recognition of and Responses to Hypoglycemia in Humans,”
Annals of Internal Medicine,
119(8), 1993, pages 799–804.

7. Keijzers, G. B., De Galan, B. E., Tack, C. J., et al.,“Caffeine Can Decrease Insulin Sensitivity in Humans,”
Diabetes Care,
25(2), 2002, pages 364–369.

8. Thong, F. S., Derave, W., Kiens, B., et al., “Caffeine-Induced Impairment of Insulin Action but Not Insulin Signaling in Human Skeletal Muscle Is Reduced by Exercise,”
Diabetes,
51(3), 2002, pages 583–590.

9. Sesso, H. D., Gaziano, J. M., Buring, J. E., et al.,“Coffee and Tea In- take and the Risk of Myocardial Infarction,”
American Journal of
Epidemiology,
149(2), 1999, pages 162–167.

10. Hegarty, V. M., May, H. M., Khaw, K. T., “Tea Drinking and Bone Mineral Density in Older Women,”
American Journal of Clinical
Nutrition,
71(4), 2000, pages 1003–1007.

11. Dulloo, A. G., Duret, C., Rohrer, D., et al.,“Efficacy of a Green Tea Extract Rich in Catechin Polyphenols and Caffeine in Increasing 24-H Energy Expenditure and Fat Oxidation in Humans,”
American Journal of Clinical Nutrition,
70(6), 1999, pages 1040–1045.

12. Hosoda, K.,Wang, M. F., Liao, M. L., et al.,“Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes,”
Diabetes Care,
26(6), 2003, pages 1714–1718.

13. Caimi, G., Carollo, C., Lo Presti, R.,“Diabetes Mellitus: Oxidative Stress and Wine
,” Current Medical Research and Opinion,
19(7), 2003, pages 581–586.

14. Avogaro,A.,Sambataro,M.,Marangoni,A.,et al.,“Moderate Alcohol Consumption, Glucose Metabolism and Lipolysis: The Effect on Adiponectin and Tumor Necrosis Factor Alpha
,” Journal of Endocrinological Investigation,
26(12), 2003, pages 1213–1218.

15. Lange, J., Arends, J., Willms, B., “Alcohol-Induced Hypoglycemia in Type I Diabetic Patients
,” Medizinisohe Klinik (Munich),
86(11), 1991, pages 551–554.

16. Swade,T.F.,Emanuele,N.V.,“Alcohol & Diabetes
,” Comprehensive
Therapy,
23(2), 1997, pages 135–140.

17. Sacks, D. B., Bruns, D. E., Goldstein, D. E., et al., “Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
,” Clinical Chemistry,
48(3), 2002, pages 436–472.

Chapter 20: Getting Extra Help: Supplements for Blood Sugar Control

1. Fletcher,R.H.,Fairfield,K.M.,“Vitamins for Chronic Disease Prevention in Adults: Clinical Applications
,” Journal of the American
Medical Association,
287(23), 2002, pages 3127–3129.

2. Barringer, T. A., Kirk, J. K., Santaniello, A. C., et al., “Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life. A Randomized, Double-Blind, Placebo-Controlled Trial,”
Annals of Internal Medicine,
138(5), 2003, pages 365–371.

3. Hayden, M. R., Tyagi, S. C.,“Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus
,” Journal of the
Pancreas,
3(4), 2002, pages 86–108.

4. Jiang, R., Manson, J. E., Meigs, J. B., et al.,“Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women,”
Journal of the American Medical Association,
291(6), 2004, pages 711–717.

5. Hayden, M. R., Tyagi, S. C.,“Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus
,” Journal of the
Pancreas,
3(4), 2002, pages 86–108.

6. Sinclair, A. J., Taylor, P. B., Lunec, J., et al.,“Low Plasma Ascorbate Levels in Patients with Type 2 Diabetes Mellitus Consuming Adequate Dietary Vitamin C,”
Diabetic Medicine,
11(9), 1994, pages 893–898.

7. Sargeant, L.A.,Wareham, N. J., Bingham, S., et al.,“Vitamin C and Hyperglycemia in the European Prospective Investigation into Cancer—Norfolk (EPIC-Norfolk) Study: A Population-Based Study,”
Diabetes Care,
23(6), 2000, pages 726–732.

8. Natali, A., Sironi, A. M., Toschi, E., et al., “Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hyper- tension,”
Arteriosclerosis,Thrombosis, and Vascular Biology,
20(11), 2000, pages 2401–2406.

9. Ting, H. H., Timimi, F. K., Boles, K. S., et al.,“Vitamin C Improves Endothelium-Dependent Vasodilation in Patients with Non-Insulin-Dependent Diabetes Mellitus,”
Journal of Clinical Investigation,
97(1), 1996, pages 22–28

10. Carr, A., Frei, B.,“The Role of Natural Antioxidants in Preserving the Biological Activity of Endothelium-Derived Nitric Oxide
,”
Free Radical Biology and Medicine,
28(12), 2000, pages 1806–1814.

11. Price, K. D., Price, K. S., Reynolds, R. D.,“ Hyperglycemia-Induced Ascorbic Acid Deficiency Promotes Endothelial Dysfunction and the Development of Atherosclerosis,”
Atherosclerosis,
158(1),2001, pages 1–12.

12. Trumbo, P., Schlicker, S., Yates, A. A., et al.,“Dietary Reference In- takes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids
,” Journal of the American Dietetic
Association,
102(11), 2002, pages 1621–1630.

13. Paolisso, G., D’Amore, A., Galzerano, D., et al., “Daily Vitamin E Supplements Improve Metabolic Control but Not Insulin Secretion in Elderly Type II Diabetic Patients,”
Diabetes Care,
16(11), 1993, pages 1433–1437.

14. Devaraj, S., Jialal, I., “Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients with and without Macro- vascular Complications: The Effect of Alpha-Tocopherol Supplementation,”
Circulation,
102(2), 2000, pages 191–196.

15. Trumbo, P., Schlicker, S., Yates, A. A., et al.,“Dietary Reference In- takes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids
,” Journal of the American Dietetic
Association,
102(11), 2002, pages 1621–1630.

16. Ametov, A. S., Barinov, A., Dyck, P. J., et al., “The Sensory Symptoms of Diabetic Polyneuropathy Are Improved with Alpha-Lipoic Acid:The Sydney Trial,”
Diabetes Care,
26(3),2003,pages 770–776.

17. Maebashi, M., Makino, Y., Kurukawa, Y., et al.,“Therapeutic Evaluation of the Effect of Biotin on Hyperglycemia in Patients with Non-Insulin Dependent Diabetes Mellitus,”
Journal of Clinical
Biochemistry and Nutrition,
14, 1993, pages 211–218.

18. McCarty, M. F.,“Toward Practical Prevention of Type 2 Diabetes
,”
Medical Hypotheses,
54(5), 2000, pages 786–793.